Invention Grant
- Patent Title: Uses of labeled HSP90 inhibitors
-
Application No.: US16934881Application Date: 2020-07-21
-
Publication No.: US11607465B2Publication Date: 2023-03-21
- Inventor: Gabriela Chiosis , Naga Vara Kishore Pillarsetty , Jason S. Lewis , Steven M. Larson , Tony Taldone , Mary L. Alpaugh , Erica M. Gomes-DaGama
- Applicant: Sloan-Kettering Institute for Cancer Research
- Applicant Address: US NY New York
- Assignee: Sloan-Kettering Institute for Cancer Research
- Current Assignee: Sloan-Kettering Institute for Cancer Research
- Current Assignee Address: US NY New York
- Agency: Choate, Hall & Stewart LLP
- Agent Michael L. Vetter
- Main IPC: A61K51/04
- IPC: A61K51/04 ; G01N33/50 ; G01N33/574 ; A61K31/52
Abstract:
This invention concerns various methods of using labeled HSP90 inhibitors to improve treatment of cancer patients with HSP90 inhibitors, including ex vivo and in vivo methods for determining whether a tumor will likely respond to therapy with an HSP90 inhibitor.
Public/Granted literature
- US20210138091A1 USES OF LABELED HSP90 INHIBITORS Public/Granted day:2021-05-13
Information query
